• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    ImmunoCellular Therapeutics, Ltd. (IMUC)

    -NYSE MKT
    0.41 Aug 28, 4:01PM EDT
    Add to Portfolio
    Prev Close:0.41
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:3.00
    Beta:1.41446
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:N/A - N/A
    52wk Range:0.35 - 1.04
    Volume:0
    Avg Vol (3m):506,822
    Market Cap:37.00M
    P/E (ttm):N/A
    EPS (ttm):-0.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMUC

    Comparison

    Symbol% ChgMkt Cap
    IMUC 0.00%37.00M
    STML172.73M
    AGEN612.07M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.17
    Quarterly EPS Est (Sep-15) :-0.06
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback